Skip to main content
. 2021 Sep 17;65(10):e01274-21. doi: 10.1128/AAC.01274-21

FIG 1.

FIG 1

In vivo change in log10 bacterial burden from 0 h in animals treated with sham control, ceftazidime 2 g every 8 h (q8h) by 2-h infusion human-simulated regimen (HSR), cefepime 1 g q8h by 2-h infusion HSR, or cefepime 2 g q8h by 2-h infusion HSR in the murine thigh infection model.